Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,950.00
Bid: 9,900.00
Ask: 10,000.00
Change: -150.00 (-1.49%)
Spread: 100.00 (1.01%)
Open: 10,050.00
High: 9,980.00
Low: 9,900.00
Prev. Close: 10,050.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

21 Mar 2011 07:00

RNS Number : 2707D
Judges Scientific PLC
21 March 2011
 

JUDGES SCIENTIFIC plc

("Judges Scientific", "Judges" or the "Company")

 

ACQUISITION OF 51% OF DEBEN UK LIMITED

 

Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, announces that it completed on 18 March the acquisition of a 51% indirect interest in Deben UK Limited ("Deben") for a cash consideration of £3.26 million (the "Acquisition").

 

An additional payment will be made to reflect the working capital available at completion in excess of the ongoing requirements of the business. Such payment is expected by Judges to be covered by the cash inherited on completion.

 

The Acquisition has been executed through Bordeaux Acquisition Limited ("BAL"), a 51% owned subsidiary of Judges, which was created for the purpose of effecting the acquisition and which acquired the entirety of Deben's share capital.

 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed through a £2,422,250 loan provided by Lloyds Bank Corporate Markets to BAL. The loan is split into two parts, both guaranteed by Judges, and comprises an acquisition component of £2.06 million and a property element of £362,250, secured against the freehold property from which Deben operates its business.

 

Equity of £1,013,250 was supplied by the BAL shareholders, pro-rata to their respective interests, predominantly in the form of subordinated loans. Gary and Tracey Edwards, the vendors of Deben, have reinvested £497,000 of their sale proceeds to acquire a 49% shareholding in BAL, while Judges invested £516,250 in respect of its 51% interest.

 

Both parties have entered into a Shareholders' Agreement which includes minority protection provisions and stipulates, inter alia, that BAL has the right of first refusal on potential acquisitions available to the Judges group, provided that such acquisitions meet certain criteria, operate in the field of electron microscopy and can be financed independently by BAL.

 

Information on Deben

Deben designs, manufactures and sells devices used to enable or improve the observation of objects under a microscope. The principal product groups are motor control systems, micro-tensile stages, cooling stages, digital imaging for electron microscopes and beam blanking equipment. The products are sold world-wide to OEM customers (microscope manufacturers that incorporate such equipment in their own instruments) or directly to end users such as universities.

 

The business, established in 1987, is based in Woolpit, Suffolk, and has been managed by Gary Edwards since 1996. It is expected that Mr Edwards, 44, will continue as managing director of Deben for the foreseeable future.

 

Deben's unaudited accounts for the year ended 31 October 2010 show sales of £2 million and pre-tax profits of £862,000. Operating profits, adjusted to eliminate non-recurring items and to reflect Judges Scientific's practices, would have amounted to £707,000. The accounts show net tangible assets of £2.25 million including net cash of £1.36 million. The freehold property was valued on BAL's behalf at £517,500. The price paid for Deben reflects this valuation as well as a multiple of adjusted operating profit.

 

The Board believes that this acquisition is an excellent addition to the Group's electron microscopy business and will be immediately earnings enhancing.

 

Alex Hambro, Chairman of Judges, commented:

"We are delighted to be able to expand our electron microscopy business through the acquisition of Deben. This is a profitable and cash generative business and we expect the transaction, which has not involved the issue of new equity, to be immediately earnings enhancing. We welcome Gary and his team into the Judges group for what we anticipate will be a long and fruitful relationship ".

 

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

 

Pascal Keane, Shore Capital: Tel: 020 7408 4090

 

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

Websites:

 Judges Scientific:www.judges.uk.com

 

Deben: www.deben.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURSSRAKAOUAR
Date   Source Headline
26th Oct 201712:19 pmRNSDirector/PDMR Shareholding
16th Oct 201712:03 pmRNSNotification of major holdings
10th Oct 20177:00 amRNSCompletion of Director Placing
9th Oct 20174:40 pmRNSPropose Director Placing
6th Oct 201711:23 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSTotal Voting Rights
19th Sep 20177:00 amRNSInterim Results for the 6M ended 30 June 2017
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:08 amRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:11 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSNotice of Results
21st Jul 20179:51 amRNSDirector/PDMR Shareholding
21st Jul 20179:20 amRNSHolding(s) in Company
20th Jul 20171:57 pmRNSDirector/PDMR Shareholding
20th Jul 20177:00 amRNSTrading Update and Notice of Interim Results
18th Jul 20177:00 amRNSAcquisition
6th Jul 20174:15 pmRNSDirector/PDMR Shareholding
6th Jul 20174:12 pmRNSDirector/PDMR Shareholding
6th Jul 20174:11 pmRNSDirector/PDMR Shareholding
7th Jun 20172:49 pmRNSDirector/PDMR Shareholding
7th Jun 20172:48 pmRNSDirector/PDMR Shareholding
7th Jun 20172:46 pmRNSDirector/PDMR Shareholding
5th Jun 201711:31 amRNSHolding(s) in Company
24th May 201712:52 pmRNSResult of Annual General Meeting
15th May 20177:00 amRNSBlocklisting Return
10th May 20173:39 pmRNSDirector/PDMR Shareholding
10th May 20173:38 pmRNSDirector/PDMR Shareholding
10th May 20173:36 pmRNSDirector/PDMR Shareholding
10th May 20173:35 pmRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSTotal Voting Rights
28th Apr 20175:10 pmRNSDirector/PDMR Shareholding
7th Apr 20178:57 amRNSDirector/PDMR Shareholding
7th Apr 20178:55 amRNSDirector/PDMR Shareholding
7th Apr 20178:54 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
21st Mar 20177:00 amRNSFinal Results
8th Mar 20172:41 pmRNSDirector/PDMR Shareholding
8th Mar 20172:40 pmRNSDirector/PDMR Shareholding
8th Mar 20172:39 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
8th Feb 20173:50 pmRNSDirector/PDMR Shareholding
8th Feb 20173:45 pmRNSDirector/PDMR Shareholding
8th Feb 20173:40 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTotal Voting Rights
23rd Jan 20177:00 amRNSTrading statement and Notice of Final Results
10th Jan 201712:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.